Another $751 million for Orbimed Asia Partners V ... The size of the commitment will be a boost for the biotech sector, which is currently in the middle of a rough patch for financing with ...

The country is experiencing rapid growth in biotechnology thanks to continuous public and private sector investment and ... to expand their presence in Asia. The country's proximity to major ...

The global Healthcare Contract Manufacturing Market size is projected to be valued at USD 183.7 billion in 2023 and reach USD 347.5 billion by 2030, growing ...

The Network Slicing Market is expected to reach USD 49.82 billion by 2030 from USD 1.94 billion in 2025, at a CAGR of 91.3%, during 2025-2030 ...

The number of people with cardiovascular disease surged by 148% in Southeast Asia over the past three decades, with the ...

Two European cleantech companies are betting that Asia's semiconductor industry is ready to embrace environmentally-focused ...

Asian healthcare-focused private equity firm Quadria Capital said on Tuesday it has secured total commitments of $1.07 billion for its third fund, surpassing an original target of $800 million.

The policy aims to create 30,000 high-quality jobs in the biotechnology sector by 2029. To achieve this, it will collaborate with over 200 institutions to equip 20,000 individuals with specialised ...

If these times have anything to say about it, the next Microsoft is coming from the biotech sector. Investors are moving in looking for profits, even putting companies without products on the map.

With Illumina currently banned from shipping its DNA sequencers into China—in retaliation for the Trump administration’s ...

Goldman Sachs is merging three Asian investment banking businesses it previously managed separately into a single unit to ...

AI-driven strategies in China and South Korea reinforce East Asia’s manufacturing dominance, challenging Western and Global ...